Glytec announced today that it raised $21 million in financing to fund its glycemic management technology.
Waltham, Mass.-based Glytec received $9 million in debt financing from Silicon Valley Bank, combined with $12 million in equity funding, led by Savitr with contribution from other private investors, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.